The progress in new drug approvals for infective disease of poverty (IDOP) in India
The global burden for infectious disease remains high in the developing and underdeveloped countries like Sub-Sahara Africa, South–East Asia and Latin America. Among them, the three major contributors of mortality and morbidity are HIV/AIDS, tuberculosis and malaria which along with neglected tropic...
Main Authors: | Manik Ghadlinge, Proteesh Rana |
---|---|
Format: | Article |
Language: | English |
Published: |
Mazandaran University of Medical Sciences
2018-11-01
|
Series: | Pharmaceutical and Biomedical Research |
Subjects: | |
Online Access: | http://pbr.mazums.ac.ir/article-1-209-en.html |
Similar Items
-
Editorial: Current approaches in infectious disease drug discovery
by: Floriano P. Silva-Jr, et al.
Published: (2022-11-01) -
The 2017 Oslo conference report on neglected tropical diseases and emerging/re-emerging infectious diseases – focus on populations underserved
by: Katharina Klohe, et al.
Published: (2019-05-01) -
Disregard of neurological impairments associated with neglected tropical diseases in Africa
by: Emmanuel Quansah, et al.
Published: (2016-06-01) -
Epilepsy and neurocysticercosis in rural areas of the Bolivian Chaco: What has changed during the last 30 years?
by: Alessandra Nicoletti, et al.
Published: (2024-04-01) -
Key Contributions by the Swiss Tropical and Public Health Institute Towards New and Better Drugs for Tropical Diseases
by: Pascal Mäser, et al.
Published: (2023-09-01)